A Reanalysis of the FDA's Benefit--Risk Assessment of Moderna's mRNA-1273 COVID Vaccine Based on a Model Incorporating Benefits Derived from Prior COVID Infection

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Bourdon, Paul S., Duriseti, Ram, Gromoll, H. Christian, Dalton, Dyana K., Bardosh, Kevin, Krug, Allison E.
Format:	Preprint
Published:	2024
Subjects:	Quantitative Methods 92-10, 92C50
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

https://arxiv.org/abs/2410.11811